Trial Details
COMPLETEDBasic Information
| Clinical ID | c1751 |
|---|---|
| Identifier | NCT04557215 |
| Trial Title | Efficacy and Safety of Rifaximin With NAC in IBS-D |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Irritable Bowel Syndrome With Diarrhea |
| Interventions | DRUG: Rifaximin|DRUG: N-acetylcysteine|DRUG: Placebo |
Participant Information
| Sponsor | Cedars-Sinai Medical Center |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2020-11-13 |
|---|---|
| Primary Completion Date | 2021-08-31 |
| Completion Date | 2022-10-30 |